Dataset: Transcription profiling of human AML to identift molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory AML
Gene signatures were derived to separate responders from nonresponders by tipifarnib treatment. Experiment Overall Design: 58 samples...
Gene signatures were derived to separate responders from nonresponders by tipifarnib treatment. Experiment Overall Design: 58 samples from 58 patients
- Species:
- human
- Samples:
- 58
- Source:
- E-GEOD-5122
- Updated:
- Dec.12, 2014
- Registered:
- Jun.19, 2014
Factors:
(via ArrayExpress)
| Sample |
|---|
| GSE5122GSM115746 |
| GSE5122GSM115701 |
| GSE5122GSM115714 |
| GSE5122GSM115739 |
| GSE5122GSM115734 |
| GSE5122GSM115729 |
| GSE5122GSM115709 |
| GSE5122GSM115747 |
| GSE5122GSM115719 |
| GSE5122GSM115723 |
| GSE5122GSM115754 |
| GSE5122GSM115742 |
| GSE5122GSM115735 |
| GSE5122GSM115715 |
| GSE5122GSM115745 |
| GSE5122GSM115743 |
| GSE5122GSM115752 |
| GSE5122GSM115706 |
| GSE5122GSM115722 |
| GSE5122GSM115713 |
| GSE5122GSM115705 |
| GSE5122GSM115730 |
| GSE5122GSM115720 |
| GSE5122GSM115724 |
| GSE5122GSM115718 |
| GSE5122GSM115733 |
| GSE5122GSM115741 |
| GSE5122GSM115732 |
| GSE5122GSM115748 |
| GSE5122GSM115737 |
| GSE5122GSM115755 |
| GSE5122GSM115700 |
| GSE5122GSM115751 |
| GSE5122GSM115740 |
| GSE5122GSM115736 |
| GSE5122GSM115721 |
| GSE5122GSM115710 |
| GSE5122GSM115716 |
| GSE5122GSM115750 |
| GSE5122GSM115731 |
| GSE5122GSM115738 |
| GSE5122GSM115753 |
| GSE5122GSM115708 |
| GSE5122GSM115711 |
| GSE5122GSM115717 |
| GSE5122GSM115712 |
| GSE5122GSM115707 |
| GSE5122GSM115698 |
| GSE5122GSM115744 |
| GSE5122GSM115725 |
| GSE5122GSM115703 |
| GSE5122GSM115726 |
| GSE5122GSM115699 |
| GSE5122GSM115728 |
| GSE5122GSM115749 |
| GSE5122GSM115704 |
| GSE5122GSM115702 |
| GSE5122GSM115727 |